Reported Standalone quarterly numbers for Pharmaids Pharmaceuticals are:
Net Sales at Rs 5.97 crore in September 2025 up 615.29% from Rs. 0.83 crore in September 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 1.65 crore in September 2025 down 64.15% from Rs. 1.01 crore in September 2024.
EBITDA stands negative at Rs. 4.38 crore in September 2025 down 291.07% from Rs. 1.12 crore in September 2024.
Pharmaids Pharm shares closed at 48.98 on November 11, 2025 (BSE) and has given -24.99% returns over the last 6 months and -38.27% over the last 12 months.
Story continues below Advertisement
| Pharmaids Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 5.97 | 1.12 | 0.83 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 5.97 | 1.12 | 0.83 | | EXPENDITURE | | Consumption of Raw Materials | 9.29 | 0.06 | -- | | Purchase of Traded Goods | -- | 0.55 | 0.62 | | Increase/Decrease in Stocks | -2.77 | 0.46 | 0.04 | | Power & Fuel | -- | -- | -- | | Employees Cost | 1.60 | 1.40 | 0.72 | | Depreciation | 0.06 | 0.05 | 0.05 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 2.43 | 3.53 | 0.59 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -4.64 | -4.93 | -1.18 | | Other Income | 0.19 | 0.35 | 0.01 | | P/L Before Int., Excpt. Items & Tax | -4.44 | -4.58 | -1.17 | | Interest | 1.02 | 1.11 | 0.01 | | P/L Before Exceptional Items & Tax | -5.46 | -5.69 | -1.19 | | Exceptional Items | 3.13 | 0.00 | -- | | P/L Before Tax | -2.33 | -5.69 | -1.19 | | Tax | -0.68 | -1.33 | -0.18 | | P/L After Tax from Ordinary Activities | -1.65 | -4.36 | -1.01 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.65 | -4.36 | -1.01 | | Equity Share Capital | 35.27 | 35.27 | 35.27 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.47 | -1.24 | -0.29 | | Diluted EPS | -0.47 | -1.24 | -0.29 | | EPS After Extra Ordinary | | Basic EPS | -0.47 | -1.24 | -0.29 | | Diluted EPS | -0.47 | -1.24 | -0.29 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
